Evidence map›Paper›PMID 39787145›Full record

ArticlePloS one2025

Knockout of the ING5 epigenetic regulator confirms roles in stem cell maintenance and tumor suppression in vivo.

Buthaina Al Shueili, Arthur Dantas, Etienne Mahe, Tak Ho Chu, Yang Yang, Elodie Labit, Eren Kutluberk, Nicolas Lasaleta, Anand Masson, Hiba Omairi and 5 more

Abstract read
In one paragraph

Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Buthaina Al ShueiliRobson DNA Sciences Centre, Calgary, Canada.
Arthur DantasRobson DNA Sciences Centre, Calgary, Canada.
Etienne MaheArnie Charbonneau Cancer Institute, Calgary, Canada.
Tak Ho ChuHotchkiss Brain Institute, University of Calgary, Calgary, Canada.ORCID 0000-0002-3123-207X
Yang YangRobson DNA Sciences Centre, Calgary, Canada.
Elodie LabitDepartments of Comparative Biology and Experimental Medicine, University of Calgary, Calgary, Canada.
Eren KutluberkDepartments of Comparative Biology and Experimental Medicine, University of Calgary, Calgary, Canada.
Nicolas LasaletaHotchkiss Brain Institute, University of Calgary, Calgary, Canada.
Anand MassonDepartments of McCaig Institute for Bone & Joint Health, University of Calgary, Calgary, Canada.
Hiba OmairiArnie Charbonneau Cancer Institute, Calgary, Canada.
Kenichi ItoDepartments of Biochemistry & Molecular Biology, University of Calgary, Calgary, Canada.
Roman J KrawetzDepartments of McCaig Institute for Bone & Joint Health, University of Calgary, Calgary, Canada.
Rajiv MidhaHotchkiss Brain Institute, University of Calgary, Calgary, Canada.
Gregory CairncrossArnie Charbonneau Cancer Institute, Calgary, Canada.
Karl RiabowolRobson DNA Sciences Centre, Calgary, Canada.ORCID 0000-0002-5318-2536

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

INhibitor of Growth (ING1-5) proteins are epigenetic readers that target histone acetyltransferase (HAT) or histone deacetylase (HDAC) complexes to the H3K4Me3 mark of active transcription. ING5 targets Moz/Morf and HBO1 HAT complexes that alter acetylation of H3 and H4 core histones, affecting gene expression. Previous experiments in vitro indicated that ING5 functions to maintain stem cell character in normal and in cancer stem cells. Here we find that CRISPR/Cas9 ING5 knockout (KO) mice are sub-fertile but show no decrease in lifespan or ability to heal wounds despite indications of depleted stem cell pools in several tissues. ING5 KO mouse embryo fibroblasts accumulate in G2 of the cell cycle, have high levels of abnormal nuclei and show high basal levels of the γH2AX indicator of DNA damage. KO animals also develop severe dermatitis at a 5-fold higher rate that wild-type littermates. Consistent with ING5 serving a tumor suppressive role, ING5 KO mice developed germinal centre diffuse large B-cell lymphomas at a rate 6-fold higher than control mice at 18 months of age. These data suggest that ING5 functions in vivo to maintain stem cell character in multiple organs, that reduction of stem cell populations is not limiting for murine lifespan and that like a subset of other ING family members, ING5 functions as a tumor suppressor in hematopoietic cells in vivo.

Indexed as

Epigenesis, GeneticMice, KnockoutTumor Suppressor ProteinsAnimalsDNA DamageFibroblastsMiceStem CellsTumor Suppressor Proteins

Identifiers

PMID39787145
PMCPMC11717183

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.